EZH2 and glioblastoma: EZH2 mechanistically upregulates c-MYC expression [104] and increases signal transducer and activator of transcription 3 (STAT3) phosphorylation [105], leading to GBM tumorigenesis and making EZH2 a compelling epigenetic target.